These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20167561)

  • 21. Possible action of vasohibin-1 as an inhibitor in the regulation of vascularization of the bovine corpus luteum.
    Shirasuna K; Kobayashi A; Nitta A; Nibuno S; Sasahara K; Shimizu T; Bollwein H; Miyamoto A
    Reproduction; 2012 Apr; 143(4):491-500. PubMed ID: 22367587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The biology of VEGF and its receptors.
    Ferrara N; Gerber HP; LeCouter J
    Nat Med; 2003 Jun; 9(6):669-76. PubMed ID: 12778165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth.
    Fahmy RG; Dass CR; Sun LQ; Chesterman CN; Khachigian LM
    Nat Med; 2003 Aug; 9(8):1026-32. PubMed ID: 12872165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous inhibitors of angiogenesis.
    Nyberg P; Xie L; Kalluri R
    Cancer Res; 2005 May; 65(10):3967-79. PubMed ID: 15899784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of laser-induced choroidal neovascularization by intravitreal vasohibin-1 in monkey eyes.
    Onami H; Nagai N; Machida S; Kumasaka N; Wakusawa R; Ishikawa Y; Sonoda H; Sato Y; Abe T
    Retina; 2012 Jun; 32(6):1204-13. PubMed ID: 22366904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical implications of angiogenesis in the treatment of cancer.
    Aoun E; Taher A
    J Med Liban; 2002; 50(1-2):32-8. PubMed ID: 12841311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate.
    Diez H; Fischer A; Winkler A; Hu CJ; Hatzopoulos AK; Breier G; Gessler M
    Exp Cell Res; 2007 Jan; 313(1):1-9. PubMed ID: 17045587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrins: the keys to unlocking angiogenesis.
    Silva R; D'Amico G; Hodivala-Dilke KM; Reynolds LE
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1703-13. PubMed ID: 18658045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis.
    Mehta VB; Zhou Y; Radulescu A; Besner GE
    Growth Factors; 2008 Dec; 26(6):301-15. PubMed ID: 18925469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of cell adhesion pathways in angiogenesis.
    Ramjaun AR; Hodivala-Dilke K
    Int J Biochem Cell Biol; 2009 Mar; 41(3):521-30. PubMed ID: 18762270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular control of physiological skin angiogenesis.
    Odorisio T; Failla CM; Zambruno G
    Eur J Dermatol; 2002; 12(6):VII-X. PubMed ID: 12506892
    [No Abstract]   [Full Text] [Related]  

  • 32. Vasohibin induces prolyl hydroxylase-mediated degradation of hypoxia-inducible factor-1α in human umbilical vein endothelial cells.
    Kozako T; Matsumoto N; Kuramoto Y; Sakata A; Motonagare R; Aikawa A; Imoto M; Toda A; Honda S; Shimeno H; Soeda S
    FEBS Lett; 2012 Apr; 586(7):1067-72. PubMed ID: 22569265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduction of angiocidin expression in human umbilical vein endothelial cells via siRNA silencing inhibits angiogenesis.
    Yang X; Rothman VL; L'Heureux DZ; Tuszynski G
    Exp Mol Pathol; 2006 Oct; 81(2):108-14. PubMed ID: 16904104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4.
    Ito Y; Oike Y; Yasunaga K; Hamada K; Miyata K; Matsumoto S; Sugano S; Tanihara H; Masuho Y; Suda T
    Cancer Res; 2003 Oct; 63(20):6651-7. PubMed ID: 14583458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function.
    Patel NS; Li JL; Generali D; Poulsom R; Cranston DW; Harris AL
    Cancer Res; 2005 Oct; 65(19):8690-7. PubMed ID: 16204037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in understanding angiogenesis through molecular studies.
    Kwon M; Libutti SK
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):26-32. PubMed ID: 16377412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amelioration of renal alterations in obese type 2 diabetic mice by vasohibin-1, a negative feedback regulator of angiogenesis.
    Saito D; Maeshima Y; Nasu T; Yamasaki H; Tanabe K; Sugiyama H; Sonoda H; Sato Y; Makino H
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F873-86. PubMed ID: 21228103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-Face of Vasohibin-1 for the Maintenance of Vascular Homeostasis and Healthy Longevity.
    Sato Y
    J Atheroscler Thromb; 2018 Jun; 25(6):461-466. PubMed ID: 29398681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinctive localization and opposed roles of vasohibin-1 and vasohibin-2 in the regulation of angiogenesis.
    Kimura H; Miyashita H; Suzuki Y; Kobayashi M; Watanabe K; Sonoda H; Ohta H; Fujiwara T; Shimosegawa T; Sato Y
    Blood; 2009 May; 113(19):4810-8. PubMed ID: 19204325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.